Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
This study evaluate the percentage of women with thin endometrium who achieve an endometrial
thickness equal to or greater than 7 mm after administration of PRGF (plasma rich in growth
factors)